Byetta

GSK's Tanzeum pulling doesn't bode well for Sanofi, AZ: analyst

GSK made waves last week by pulling GLP-1 laggard Tanzeum from the market. And that move could signal weak sales ahead for other bottom-feeders in the class.

Carly Helfand Jul 31, 2017 10:21am

Lilly's ADHD med Strattera faces generic stampede

May 31, 2017 9:42am

AZ taps 3SBio to help drive sales of Byetta, Bydureon in China

Oct 13, 2016 9:49am

Report finds Sanofi GLP-1 med has safety edge over Victoza

Aug 19, 2016 9:22am

Sanofi nabs long-sought FDA nod for diabetes med Adlyxin

Jul 28, 2016 9:56am

AstraZeneca puts top brands on one-size-fits all mobile app

Jun 19, 2016 11:34am